Found: 6
Select item for more details and to access through your institution.
Predictive Factors of Antibody–Drug Conjugate Treatment in Metastatic Breast Cancer: A Narrative Review.
- Published in:
- Cancers, 2024, v. 16, n. 23, p. 4082, doi. 10.3390/cancers16234082
- By:
- Publication type:
- Article
Characterization of a Rare Nonpathogenic Methylenetetrahydrofolatereductase ( MTHFR) Gene Mutation p.Lys215del in a Southern Italian family.
- Published in:
- Human Mutation, 2017, v. 38, n. 1, p. 120, doi. 10.1002/humu.23132
- By:
- Publication type:
- Article
The Mediterranean Lifestyle to Contrast Low-Grade Inflammation Behavior in Cancer.
- Published in:
- Nutrients, 2023, v. 15, n. 7, p. 1667, doi. 10.3390/nu15071667
- By:
- Publication type:
- Article
Evaluating CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Retrospective Real-World Multicenter Study.
- Published in:
- Cancers, 2024, v. 16, n. 20, p. 3442, doi. 10.3390/cancers16203442
- By:
- Publication type:
- Article
Immune-related adverse events during anticancer immunotherapy: Pathogenesis and management (Review).
- Published in:
- Oncology Letters, 2017, v. 14, n. 5, p. 5671, doi. 10.3892/ol.2017.6919
- By:
- Publication type:
- Article
Synergizing Immunotherapy and Antibody–Drug Conjugates: New Horizons in Breast Cancer Therapy.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 9, p. 1146, doi. 10.3390/pharmaceutics16091146
- By:
- Publication type:
- Article